The global Herbal Pharmaceuticals market has witnessed a paradigm shift in recent years. As the world moves toward holistic wellness and preventive medicine, the demand for standardized Traditional Chinese Medicine (TCM) and botanical extracts has surged. Valued at billions of dollars, the industry is no longer confined to local markets but serves as a cornerstone of the global bio-pharmaceutical sector. From the bustling clinics in North America to the research labs in Europe, herbal products are being integrated into mainstream healthcare systems.
🔍 Technological Integration: The modern era of herbal medicine is defined by "Smart Pharmacy" concepts. This involves the transition from raw, unprocessed herbs to highly concentrated, pure, and standardized granules and capsules. This evolution addresses the historical challenges of consistency and dosage accuracy, making herbal medicine a reliable option for global practitioners.
📈 Market Trends: Current trends indicate a massive push toward "Clean Label" products. Procurement officers worldwide are prioritizing suppliers who can provide complete traceability—from the soil quality of the planting base to the final extraction process. There is also a growing synergy between AI-driven diagnostics and personalized herbal prescriptions, a field where Neo-Green Herbs is a pioneer.
International wholesalers and medical institutions require stable supply chains, rigorous GMP certifications, and competitive pricing. Our B2B model is designed to fulfill these high-volume requirements without compromising on purity.
We don't just supply; we innovate. Our parent company, NGP, has been researching Smart TCM Pharmacy solutions since 2002, ensuring every granule represents the pinnacle of pharmaceutical science.
Navigating the complex regulations of the FDA, EMA, and other bodies is crucial. Our products come from verified, certified channels, ensuring complete safety for your patients and legal compliance for your business.
Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. (NGP), was founded in 2023. We are inheriting and popularizing the millennial-long TCM culture through modern techniques. As one of the only six pilot manufacturers approved in China for TCM granules, we hold a unique position in the global market.
With total assets exceeding 30 billion RMB and a workforce of over 5,000 employees, we are a titan in the bio-pharmaceutical industry. Our mission is to safeguard global health through an efficient B2B supply chain, serving TCM clinics, wholesalers, and medical institutions worldwide.
Countries Served
Dedicated Employees
Patent Applications
Planting Bases
Why source from China? China is the birthplace of TCM, offering a complete industrial chain that no other region can replicate. Our facility in Sichuan leverages the rich biodiversity of the region, combined with a Circular Economy model. We manage everything from organic fertilizer integration to the environmental use of medicinal dregs. This ensures that our Herbal Pharmaceuticals are not only potent but also sustainably produced.
Professional workshops according to GAP standards. Our quality assurance team monitors every stage using advanced methodologies to guarantee purity and potency.
Since 2009, NGP has led the industry as a "National Key Leading Enterprise." We are the only TCM granule enterprise in Southwestern China with this level of accreditation.
Our products are utilized across diverse professional settings:
Provide comprehensive and high-quality pharmaceutical supply chain solutions for traditional Chinese medicine practitioners and clinics worldwide.
CONTACT US TODAYFounded in 2009, Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (NGP) is a comprehensive TCM enterprise integrating research and development, production and operation. As a “National Enterprise Technology Center” and “High-tech Enterprise”, NGP is not only one of the six pilot manufacturers approved by China for the formulation and production of TCM granules, but also the only TCM granule enterprise in the southwestern region of China.
NGP has actively responded to national investment strategies, investing in the construction of more than 300 production bases across Jiangxi, Yunnan, Chongqing, and more. This investment, totaling tens of billions of dollars, provides a solid foundation for the company’s long-term development and global supply capability.
We have pioneered the concept of the “New Circular Economy of Traditional Chinese Medicine.” This includes a whole industrial chain mode: planting, breeding, fertilizer integration, and the environmental protection use of dregs. This creates a sustainable cycle that benefits both the consumer and the environment.
Neo-Green Herbs
